Literature DB >> 12967062

Recognition and treatment of depression in Parkinson's disease.

Daniel Weintraub1, Paul J Moberg, John E Duda, Ira R Katz, Matthew B Stern.   

Abstract

Depression in Parkinson's disease (PD) is common, but little is known about its recognition and treatment. The authors report the antidepressant experience (N = 100) and outcome of depression assessment (n = 77) of a convenience sample of patients at a PD center. Subjects were assessed with a psychiatric and neurological battery, and information was gathered on depression treatment. One third (34%) of subjects met criteria for a depressive disorder, and two thirds (65%) of them were not currently receiving antidepressant treatment. Approximately one quarter (23%) of subjects were taking an antidepressant, but almost half (47%) of them still met criteria for a depressive disorder. Few antidepressant users with persistent depression had received either antidepressant treatment at dosages within the highest recommended range (11%) or more than 1 antidepressant trial (33%). Most depressed patients are untreated, and half of antidepressant users remain depressed, suggesting that even when delivered, treatment is often inadequate or ineffective.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967062     DOI: 10.1177/0891988703256053

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  69 in total

Review 1.  Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment.

Authors:  Karen L Eskow Jaunarajs; Mariana Angoa-Perez; Donald M Kuhn; Christopher Bishop
Journal:  Neurosci Biobehav Rev       Date:  2010-07-06       Impact factor: 8.989

Review 2.  The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.

Authors:  Gretchen O Reynolds; Michael W Otto; Terry D Ellis; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2015-12-30       Impact factor: 10.338

3.  Parkinson disease: Scales to detect depression in Parkinson disease.

Authors:  Anette Schrag; Albert F Leentjens
Journal:  Nat Rev Neurol       Date:  2012-05-15       Impact factor: 42.937

4.  Research priorities in geriatric palliative care: nonpain symptoms.

Authors:  Sara Combs; Benzi M Kluger; Jean S Kutner
Journal:  J Palliat Med       Date:  2013-07-26       Impact factor: 2.947

5.  Attitudes regarding the etiology and treatment of depression in Parkinson's disease: a qualitative study.

Authors:  Katherine Oehlberg; Frances K Barg; Gregory K Brown; Donna Taraborelli; Matthew B Stern; Daniel Weintraub
Journal:  J Geriatr Psychiatry Neurol       Date:  2008-06       Impact factor: 2.680

Review 6.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

Review 7.  The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review.

Authors:  Albert F G Leentjens
Journal:  Drugs       Date:  2011-02-12       Impact factor: 9.546

8.  Antidepressant treatment of veterans with Parkinson's disease and depression: analysis of a national sample.

Authors:  Peijun Chen; Helen C Kales; Daniel Weintraub; Frederic C Blow; Lan Jiang; Alan M Mellow
Journal:  J Geriatr Psychiatry Neurol       Date:  2007-09       Impact factor: 2.680

9.  Barriers to mental health care utilization in Parkinson's disease.

Authors:  Roseanne D Dobkin; Jade Tiu Rubino; Jill Friedman; Lesley A Allen; Michael A Gara; Matthew Menza
Journal:  J Geriatr Psychiatry Neurol       Date:  2013-04-15       Impact factor: 2.680

10.  Problem solving therapy for the treatment of depression for a patient with Parkinson's disease and mild cognitive impairment: a case study.

Authors:  R Scott Mackin; Patricia Areán; Alexandra Elite-Marcandonatou
Journal:  Neuropsychiatr Dis Treat       Date:  2006-09       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.